The duration of the third stage in relation to postpartum hemorrhage.

Birth

Department of Obstetrics and Gynecology, Diakonessenhuis Utrecht, Utrecht, The Netherlands.

Published: December 2019


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: In this study, we describe the distribution of placenta delivery and the incidence of postpartum hemorrhage in both spontaneous placental delivery and manual removal of the placenta.

Methods: A retrospective study was performed of 7603 singleton vaginal deliveries of a gestational age over 32 weeks, registered between September 2011 and 2016. We calculated the incidence of postpartum hemorrhage (≥1000 mL blood loss) per 10-minute duration of the third stage. The odds ratio for developing postpartum hemorrhage was assessed, adjusted for risk factors. The incidence of postpartum hemorrhage was compared between women that did and did not receive manual removal of placenta.

Results: The median duration of the third stage was 10 minutes (interquartile range 7-16 minutes). The median amount of blood loss was 300 mL (200-400 mL). The overall incidence of postpartum hemorrhage was 8.5%. With every additional 10 minutes of third-stage duration, the risk of developing postpartum hemorrhage significantly increased. In a third stage longer than 60 minutes, the incidence of postpartum hemorrhage was 21.2% without manual removal of the placenta and 70.3% with manual removal.

Conclusions: The incidence of postpartum hemorrhage increases significantly from 10 to 19 minutes into the third stage. Women with the removal of the placenta had a significantly higher percentage of postpartum hemorrhage. The optimal timing for manual removal of the placenta should be investigated in a carefully designed randomized controlled trial to examine whether earlier manual removal of placenta lowers the incidence and limits the severity of postpartum hemorrhage.

Download full-text PDF

Source
http://dx.doi.org/10.1111/birt.12441DOI Listing

Publication Analysis

Top Keywords

postpartum hemorrhage
44
incidence postpartum
24
third stage
20
manual removal
20
removal placenta
16
duration third
12
postpartum
11
hemorrhage
11
blood loss
8
developing postpartum
8

Similar Publications

Introduction: Women who experience postpartum hemorrhage (PPH) after giving birth rapidly lose blood, which may lead to shock or death without immediate intervention. PPH most often results from uterine atony, when the uterus fails to contract after delivery. Worldwide, PPH causes 10 deaths hourly, with most deaths occurring in low-income settings.

View Article and Find Full Text PDF

Drug-associated postpartum hemorrhage: a comprehensive disproportionality analysis based on the FAERS database.

Naunyn Schmiedebergs Arch Pharmacol

September 2025

Department of Pharmacy, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Maternity and Child Health Hospital, Fujian Medical University, #18 Daoshan Road, Fuzhou, Fujian, 350001, China.

Postpartum hemorrhage (PPH) is a life-threatening obstetric complication. We aimed to identify the drugs that associated with PPH based on the FDA Adverse Event Reporting System (FAERS) data, providing scientific evidence for targeted prevention of drug-related PPH risk factors. Data from 2004Q1 to 2025Q1 were extracted from FAERS, and disproportionality analysis was performed to identify potential drug signals.

View Article and Find Full Text PDF

[How I do… A vacuum-induced uterine tamponade using a Foley catheter in cases of post-abortion or postpartum hemorrhage - Presentation of FOCUS technique].

Gynecol Obstet Fertil Senol

September 2025

Northwell Health, New Hyde Park, New York, États Unis D'Amérique; Department of Obstetrics and Gynecology South Shore University Hospital, Bay Shore, New York, États Unis D'Amérique; Department of Obstetrics and Gynecology Huntington Hospital, Huntington, New York, États Unis D'Amérique; Zucke

View Article and Find Full Text PDF

Adverse Pregnancy Outcomes in Patients with Congenital Uterine Anomalies: Evaluation of a Population Dataset.

Am J Perinatol

September 2025

Division of Maternal and Fetal Medicine, OB/GYN and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, United States.

This study aimed to characterize the risk of adverse pregnancy outcomes among patients with congenital uterine anomalies (CUA) using electronic health record data.Retrospective cohort study utilizing the TriNetX analytics research network, including female patients aged 10 to 55 with a documented singleton and intrauterine pregnancy.A total of 561,440 patients met inclusion criteria, of whom 3,381 (0.

View Article and Find Full Text PDF

Objective: To compare maternal and neonatal adverse outcomes between women who are English proficient (EP) and those who have limited English proficiency (LEP).

Design: Retrospective cohort study.

Setting: Single US academic medical centre with interpreter services.

View Article and Find Full Text PDF